Objective Sympathetic neuronal activity in the thymus and lymph nodes is differentially regulated during reproductive aging. The aim was to investigate the role of estrogen on sympathetic neuronal expression in the thymus and mesenteric lymph nodes of early middle-aged ovariectomized female rats implanted with 17b-estradiol pellets. Methods 17b-Estradiol pellets (0.6 and 300) were implanted subcutaneously in ovariectomized middle-aged female Sprague-Dawley rats (n = 8/group) for a period of 30 days. At the end of the treatment period, the thymus and mesenteric lymph nodes were isolated and analyzed for the expression of tyrosine hydroxylase, nerve growth factor, and p-ERK, p-CREB and p-Akt. Results The age-related increase in tyrosine hydroxylase expression in the thymus was abrogated by ovariectomy, while estrogen suppressed it further and nerve growth factor expression was altered based on the dose of estrogen. In contrast, estrogen increased tyrosine hydroxylase and nerve growth factor expression in the mesenteric lymph nodes. Estrogen enhanced p-ERK/ total ERK, CREB/total CREB and p-Akt/total Akt expression in a dose-dependent manner. Free radical generation was augmented by estrogen in the thymus alone. Conclusions These results suggest that estrogen differentially influences sympathetic neuronal activity in the primary and secondary lymphoid organs to influence immunity.
Introduction
Reproductive senescence in women is marked by a gradual decline in gonadal hormones followed by acyclicity during menopause leading to age-associated diseases, such as osteoporosis, autoimmune and neurodegenerative diseases, and hormonedependent cancer as a result of dysregulation in the neuroendocrine-immune network. [1] [2] [3] With advancing age, estrogen promotes female-specific diseases through immunomodulation of type 1 T helper (Th1)/Th2 immunity, antibody production and inflammatory cytokines, which depend on estrogen concentrations and its receptors, and signaling pathways. 4, 5 In addition, low levels of estrogen in old rats are accompanied by a loss of catecholaminergic neuronal activity in the hypothalamus and sympathetic noradrenergic (NA) activity in the secondary lymphoid organs. [6] [7] [8] The loss of sympathetic NA innervation along with lower levels of norepinephrine (NE) concentration in the secondary lymphoid organs, spleen and lymph nodes, begins during early middle age accompanied by immunosuppression, while estrogen treatment reverses these age-associated deficiencies. [8] [9] [10] In the primary lymphoid organ, the thymus, NA innervation and NE concentration show a different pattern characterized by increased sympathetic neuronal innervation as a result of its progressive involution with aging. 2, 8 Age-related thymic regression is associated with a decrease in cellularity and loss of tissue organization leading to reduction in na€ ıve Tcell output and thus, reducing its subset diversity that diminishes its ability to counter antigenic challenge, and eventually, resulting in immunosenescence. 2, 11, 12 Estrogen is known to have detrimental effects on thymocytes by reducing thymic cellularity and depletion of early thymic progenitors that might be estrogen receptor-a-dependent. [13] [14] [15] Chemical sympathectomy decreased thymic weight, cellularity and the number of circulating peripheral T lymphocytes, altered proliferation of thymocytes, and increased apoptosis implying that catecholamines might promote T-cell viability and function in the thymus. 2, 16, 17 However, the role of estrogen in an age-associated increase of sympathetic NA fiber density due to thymic involution during early middle age is unknown.
Mesenteric lymph nodes (MLN), a secondary lymphoid organ, are responsible for trapping enteric pathogens, and are richly innervated with sympathetic NA nerve fibers that decline with age, and therefore, are possibly involved in altering gut-associated mucosal immunity. 2, 8 Nerve growth factor (NGF) is one of the many neurotrophins involved in the maintenance and development of sympathetic NA fibers, and is crucial to the modulation of immunity. 18, 19 In MLN, ex vivo and de novo estrogen markedly altered the Th1 immunity with a propensity towards Th2 immunity, and also regulated the functions of leukocytes. 20, 21 Understanding the interactions between estrogen and the sympathetic NA neuronal system, and the associated molecular mechanisms in the thymus and MLN is important in recognizing their role in immune responses in these organs, and for the effective development of therapeutic strategies against female-specific diseases. The present study was carried out to investigate and compare the effects of 30-day subcutaneous estrogen pellet implants on neuronal activity (phosphorylated tyrosine hydroxylase (p-TH)), growth factor (NGF), cell signaling molecules (ERK, CREB and Akt), levels of reactive oxygen species (ROS) and compensatory mechanisms (anti-oxidant enzymes, lipid peroxidation and free radical production) in the thymus and MLN of middle-aged ovariectomized female rats.
Methods

Animals
Young and early middle-aged female Sprague-Dawley rats were purchased from the National Institute of Nutrition, Hyderabad, India, and housed for acclimatization at the University's Animal House supplied with food pellets and water ad libitum. The experiments began when the young rats reached the age of 3 months and the middle-aged rats were aged 8-9 months. Estrous cycles were monitored by vaginal smears for 8-10 days to establish regular cyclicity of the young and middle-aged rats. All animal experiments were carried out in accordance with the principles and procedures outlined and approved by the Institutional Animal Ethics Committee.
Treatment
The early middle-aged Sprague-Dawley female rats (MA) were either sham-operated or ovariectomized (OVX), and randomly distributed into a sham-operated control group (MA sham; n = 8), a placebotreated OVX group (MA OVX + placebo; n = 8) and two estrogen treatment groups (MA OVX + E 0.6 lg; n = 8 and MA OVX + E 300 lg; n = 8). A separate group of young 3-month-old female rats (young; n = 8) served as control animals. Initially, the middle-aged female rats were either sham operated or bilaterally OVX, and after a week of recovery, 30-day placebo or estrogen pellets (17b-estradiol [0.6 lg or 300 lg], Innovative Research America, Florida, USA) were implanted subcutaneously into the nape of the neck. The doses were selected based on a preliminary study in our laboratory and a published study. 9, 10, 22 At the end of the treatment period, the animals were killed by decapitation between 08.00 to 10.00 hours. The thymus and MLN were isolated, and were frozen at À80°C for expression of signaling molecules, western blot analysis and antioxidant enzyme assays.
Intracellular signaling pathway markers
Homogenization of the thymus and MLN tissues was carried out in 5 mmol/L Tris buffer with phenylmethylsulfonyl fluoride, orthovanadate and radioimmunoprecipitation assay buffer. 5, 23, 24 After lysis, the samples were analyzed for ERK, p-ERK, CREB, p-CREB, Akt and p-Akt using enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN, USA). Briefly, 0.2 lg/mL of the primary antibodies was coated on Corning COSTAR maxisorp enzyme-linked immunosorbent assay plates (SigmaAldrich, St. Louis, MO, USA) and incubated at 37°C overnight. The next day, the plates were washed (phosphate-buffered saline with 0.05% Tween), blocked (phosphate-buffered saline with 5% bovine serum albumin Fraction V) for 2 h, washed again and incubated with 100 lL of the cell lysates or appropriate standards for 2 h at 37°C. After 2 h, the plates were washed, treated with appropriate detection antibody (0.2 lg/mL) for 1 h, followed by treatment with horseradish peroxidase (HRP)-tagged secondary antibody and 3,3 0 ,5,5 0 -tetramethylbenzidine (TMB; Sigma-Aldrich) substrate for quantification of the TMB-HRP colorimetric reaction. The reaction was stopped 20 min after substrate addition using 2 N sulphuric acid, and the plates were read at 450 nm using a microplate reader. The amount of ERK, p-ERK, CREB, p-CREB, Akt and p-Akt in samples were determined by extrapolation to the standard curve (2000 pg/mL to 20 pg/mL).
Western blot analysis
Western blot analysis for p-TH and NGF was carried out as described previously. 24 Briefly, tissues were homogenized in lysis buffer (0.005 mol/L Tris, 0.001 mol/L ethylenediaminetetraacetic acid, 100 lg/mL phenylmethylsulfonyl fluoride, 1 mmol/ L activated sodium orthovanadate), centrifuged at 252 g for 15 min and the supernatants were used for western blotting. Protein concentration was estimated using Folin and Ciocalteu's phenol reagent (Sigma-Aldrich). Then, 30 lg of total protein was electrophoresed on 10% sodium dodecylsulfatepolyacrylamide gels and blotted on 0. Cruz, CA, USA). The blots were then washed with Tris-buffer saline, and incubated with HRP-anti rabbit immunoglobulin G and anti-mouse immunoglobulin G (1:10000; Santa Cruz Biotechnology) and developed using chemiluminescent substrate (Pierce, Rockford, IL, USA). Western blotting was carried out for at least seven samples per group and twice for each sample, and quantified using densitometry in terms of relative intensity of the blots with reference to control. Signal intensity of the various molecular markers was measured by densitometric analysis using ImageJ 1.45 software (National Institutes of Health, Rockville, MD, USA).
Anti-oxidant enzyme assays
The activities of anti-oxidant enzymes were measured as described previously. 24 Briefly, the superoxide dismutase activity was measured in terms of percentage inhibition of epinephrine autooxidation. 25 The sample was diluted using 0.1 mol/ L carbonate buffer (pH 10) with the addition of equal volumes of 0.6 mmol/L ethylenediaminetetraacetic acid and 1.3 mmol/L epinephrine in carbonate buffer. Subsequently, the samples were vortexed and the absorbance was measured at 480 nm in a spectrophotometer at time intervals of 0, 30 and 60 s.
The total catalase activity was measured by a hydrogen peroxide-based assay where it forms a complex with ammonium molybdate. 26 The sample was suspended in 60 mmol/L sodium phosphate buffer (pH 7.4) with 65 mmol/L hydrogen peroxide solution and incubated for 4 min, after which the reaction was stopped using 32.4 mmol/L ammonium molybdate and the optical density was measured at 405 nm.
The glutathione peroxidase activity was measured using Ellman's Reagent. 27 The sample was diluted in 0.4 mol/L phosphate buffer (pH 7), 10 mmol/L sodium azide, 4 mmol/L reduced glutathione, 2.5 mmol/L hydrogen peroxide and incubated for 0, 1.5 and 3 min, after which the reaction was stopped with 10% trichloroacetic acid and centrifuged. To the supernatant, 0.3 mol/L disodium hydrogen phosphate solution and 1 mmol/L di-thio-nitro-benzene in 1% sodium citrate were added, after which the optical density was read immediately at 412 nm with a spectrophotometer.
For estimating the activity of glutathione-S-transferase (GST), the sample was diluted in 0.5 mol/L phosphate buffer pH 6.5 to which 25 mmol/L 1-chloro 2, 4-dinitrobenzene in 95% ethanol and 20 mmol/L reduced glutathione were added. 28 The optical density was read immediately at 340 nm in a spectrophotometer at 30-s intervals for 1.5 min.
Lipid peroxidation
The extent of lipid peroxidation was measured in terms of formation of adducts with thiobarbituric acid. 29 The sample was treated with ice-cold 10% trichloroacetic acid for precipitation of proteins, incubated for 15 min and centrifuged at 2200 g for 15 min. The obtained supernatants were treated with equal volumes of 0.67% thiobarbituric acid and incubated in a boiling water bath for 10 min. After cooling, the optical density was measured at 532 nm using a spectrophotometer. The standard curve was obtained using serial dilutions of 1, 1, 3, 3-tetraethoxypropane or malondialdehyde in distilled water.
Assay for ROS
ROS was measured by the conventional chemiluminescence assay using luminol (5-amino-2, 3 dihydro-1, 4 pthalazinedione) as a probe that reacts quickly with both intracellular and intercellular free radicals. Test samples consisted of luminol (5 mmol/ L) and phosphate-buffered saline. 30 Negative controls were prepared by replacing the sample with phosphate-buffered saline. Chemiluminescence was measured using a Luminometer (GloMax 20/20 Single Tube Luminometer; Promega, Madison, WI, USA). The result was expressed as relative light units.
Statistical analysis
Differences between groups were measured using ANOVA by the SPSS software package (SPSS Inc., Chicago, IL, USA). Parameters that attained significance (P < 0.05) with ANOVA were further analyzed by Fisher's least significant difference test. All values are expressed as mean AE SEM.
Results
Estrogen treatment on the expression of p-TH and NGF
Thymus
An age-related increase in p-TH expression was observed in MA sham-operated rats compared with young controls (Fig. 1a,b) . There was a significant (P < 0.05) decline in p-TH and NGF expression in ovariectomized rats compared with MA sham-operated rats. Both doses of estrogen (0.6 lg and 300 lg) significantly (P < 0.05) decreased the expression of p-TH, whereas a low dose of estrogen increased the NGF expression and a high dose decreased it.
MLN
Although there was a tendency for the expression of p-TH and NGF to decline with age and ovariectomy in early MA rats, it was not significant (Fig. 2a,b) . The expression of p-TH and NGF significantly (P < 0.05) increased in MA OVX rats treated with both the doses of estrogen.
Estrogen treatment on the expression of p-ERK/total ERK, p-CREB/total CREB, and p-Akt/total Akt in the thymus and MLN Both doses of estrogen treatment (0.6 lg and 300 lg) significantly (P < 0.05) enhanced the p-ERK/total ERK and p-CREB/total CREB expression in early MA OVX rats, whereas a high dose of estrogen (300 lg) alone increased the p-Akt/total Akt expression compared with placebo-treated MA OVX rats (Figs 3,4) .
Estrogen treatment on the activities of anti-oxidant enzymes and the extent of lipid peroxidation Thymus An age-related decline in the activities of superoxide dismutase, catalase (CAT), glutathione peroxidase (GPx) and GST activities was observed in MA shamoperated rats compared with young controls (Table 1) . Ovariectomy further reduced the activities of superoxide dismutase and GPx in early MA OVX rats compared with MA sham-operated rats. Treatment with both the doses of estrogen (0.6 lg and 300 lg) significantly (P < 0.05) enhanced the GPx and GST activities, whereas only the high dose of estrogen (300 lg) increased the CAT activity compared with placebo-treated MA OVX rats.
There was a significant (P < 0.05) age-related increase in the extent of lipid peroxidation in MA sham-operated rats, but ovariectomy decreased in the placebo-treated MA OVX rats. However, treatment with both doses of estrogen (0.6 lg and 300 lg) increased the extent of lipid peroxidation in middle-aged OVX rats. MLN A significant (P < 0.05) age-associated decline in the activity of GST was observed in MA sham-operated rats compared with young controls (Table 1) . A significant (P < 0.05) decline in the activities of CAT and GST was observed in MA OVX rats compared with MA sham-operated rats. Both doses of estrogen (0.6 lg and 300 lg) significantly (P < 0.05) enhanced the activities of GPx and GST, whereas only a low dose of estrogen increased the activities of superoxide dismutase and CAT in MA OVX rats compared with placebo-treated MA OVX rats.
Similar to the thymus, there was an age-related increase in the extent of lipid peroxidation in MA sham-operated rats compared with young controls. Ovariectomy decreased the extent of lipid peroxidation, but a high dose of estrogen (300 lg) alone significantly (P < 0.05) increased the extent of lipid peroxidation compared with placebo-treated MA OVX rats.
Estrogen treatment on ROS production
Thymus A significant (P < 0.05) age-related increase in ROS was observed in sham-operated MA rats compared with young controls, whereas it declined in MA OVX rats (Fig. 5) . However, ROS production increased significantly (P < 0.05) in MA OVX rats treated with both doses of estrogen compared with placebo-treated MA OVX rats. Figure 3 The expression of p-ERK/total ERK, p-CREB/total CREB and p-Akt/total Akt using enzyme-linked immunosorbent assay in the thymus after 30 days of in vivo estrogen pellet implants (0.6 lg and 300 lg) in ovariectomized (OVX) middle-aged (MA) female Sprague-Dawley rats. § P < 0.05 compared with MA OVX + placebo.
MLN
ROS production was unaltered with age, but decreased significantly (P < 0.05) in placebo-treated MA OVX rats compared with MA sham-operated rats (Fig. 6) . Unlike the thymus, ROS production did not increase in MLN after estrogen treatment.
Discussion
The results of the present study showed distinct contrasting effects of estrogen treatment on the expression of p-TH and NGF in the thymus and MLN. In the thymus, estrogen reduced p-TH expression, whereas a low dose of estrogen increased and a high dose of estrogen suppressed NGF expression. Both doses of estrogen enhanced the p-ERK and p-CREB expression, whereas a high dose alone increased pAkt expression in the thymus and MLN. There was an age-related increase in ROS production, whereas estrogen reversed the ovariectomy-induced reduction in its levels in the thymus. In contrast to the thymus, ROS levels did not increase with estrogen supplementation in MLN. These results suggest that estrogen differentially regulates sympathetic NA neuronal expression depending on the dose and lymphoid organ. In an earlier study, we reported that treatment of OVX middle-aged female rats with estrogen significantly increased its level in the serum. 31 Thymus atrophies with age, with an apparent increase in sympathetic NA innervations reflected by increased TH mRNA and expression levels, NA nerve fiber density, and NE levels. [32] [33] [34] [35] [36] In Figure 4 The expression of p-ERK/total ERK, p-CREB/total CREB and p-Akt/total Akt using enzyme-linked immunosorbent assay in mesenteric lymph nodes after 30 days of in vivo estrogen pellet implants (0.6 lg and 300 lg) in ovariectomized (OVX) middle-aged (MA) female Sprague-Dawley rats. § P < 0.05 compared with MA OVX + placebo. Mean AE SEM. *P < 0.05 compared with young, **P < 0.05 compared with middle-aged (MA) sham, ***P < 0.05 compared with MA ovariectomized (OVX) + placebo. CAT, catalase; E, estrogen; GPx, glutathione peroxidase; GST, glutathione-S-transferase; SOD, superoxide dismutase; TBARS, thiobarbituric acid reactive substances.
study, the age-associated increase in the p-TH expression was reversed with ovariectomy in the thymus that might be related to lower levels of NE and NA innervation. 32 Estrogen treatment further reduced the p-TH expression, suggesting that there mgiht be a hormone-induced decline in thymic NA innervation. In addition, estrogen might promote the loss of various subsets of T cells due to a reduction in early thymic progenitor cells and the arrest of T-cell maturation through estrogen receptor-a and the Fas/FasL pathway. [13] [14] [15] 37 It is possible that despite the increased expression of cell survival signals, p-ERK and p-Akt, the increased expression of p-CREB would have promoted thymic atrophy through the activation of the b-adrenoceptor/cyclic adenosine monophosphate/protein kinase-A pathway, and inducing the pro-apoptotic gene expression of Bim in the thymus. 38 Although ERK and Akt are implicated in T-cell differentiation and maturation in the thymus, the role of estrogen in modulating lymphopoiesis through these pathways is yet to be determined. 39, 40 Nerve growth factor is crucial to the maintenance of sympathetic neuronal survival, and is also involved in the differentiation and maturation of T cells in the thymus. 41 In the present study, there was a reduction in NGF expression after ovariectomy and high-dose estrogen treatment, while a low dose of estrogen increased its expression. It is possible that low levels of NGF could interfere with the functions of thymic epithelial cells and cytokine production in providing nourishment to the developing thymocytes to favor thymic involution. 42 The dose-and lymphoid organ-dependent effects show the differential effects of the physiological and pharmacological actions of estrogen on neuronal markers, immune parameters and intracellular signaling molecules, not only in the thymus and MLN, but also in the spleen and skin-draining lymph nodes. 9, 10 These findings warrant further studies across various stages of middle age to determine the mode of estrogen-induced alterations in the reproductive aging process.
In contrast to the thymus, sympathetic NA innervation in the MLN declines with age, and might be related to heightened immune reactivity because of its involvement in mucosal immunity. 2, 8 Secondary lymphoid organs are exposed to antigens for a longer period of time, and the ensuing immune response leads to the generation of free radicals by the production of NE and oxidative metabolites. 2, 3 Estrogen treatment enhanced the expression of both p-TH and NGF in MLN, showing that it reversed the agerelated decline in sympathetic NA nerve fibers through enhanced neurotrophin levels that is similar to its effect on splenic NGF expression. 9 An increase in p-ERK expression by estrogen suggests that it might have restored T-cell functions, because inhibition of the p-ERK pathway by corticosterone suppressed T-cell proliferation and interleukin-2 production in MLN that was associated with increased bacterial translocation. 42 Upregulated expression of p-CREB by estrogen in the MLN could prevent an inflammatory environment in the intestine and enhance mucosal immunity. 43 Estrogen-mediated decrease and an increase in p-TH expression in the thymus and MLN, respectively, might be associated with the levels of ROS production. Enhanced ROS production by estrogen in the thymus might promote the loss of sympathetic nerve fibers associated with altered T-cell maturation and differentiation, as ROS is known to interfere with cell survival and proliferation, and promote an inflammatory environment. 44, 45 Despite estrogeninduced upregulation of NGF and anti-oxidant enzyme activities, the loss of p-TH expression might have been the result of robust Bax-induced ROS burst in the thymus. 46 In contrast, the downregulation of ROS production by estrogen in MLN might have prevented activation of apoptotic pathways, and allowed the maintenance of sympathetic neurons by NGF. It is unknown whether the effects of estrogen on ROS production in lymph nodes is siteand/or cell type-dependent, because in an earlier study, a low dose of estrogen increased the production of ROS in the lymphocytes of axillary and inguinal lymph nodes. 10 The age-related decline in the immune reactivity of secondary lymphoid organs might also be due to the decline in the activities of anti-oxidant enzymes and lipid peroxidation in lymphoid organs with age. 47, 48 Estrogen-induced differential expression of p-TH in the thymus and MLN mgiht be due to altered generation of ROS in these lymphoid organs that can influence diverse signaling pathways in these organs to promote thymic atrophy or upregulation of immune reactivity in MLN. 5, 9, 10, 49 In summary, the results from the present study show the dual effects of estrogen on TH and NGF expression in the thymus and MLN that might be related to ROS production. Further studies are required to understand the molecular basis for these actions through the involvement of a subset of immune cells, cytokines and other intracellular signaling molecules.
